On January 7, 2020, leading experts in cancer immunotherapy presented an overview of the publication "The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma (RCC)" during a live webinar. The recorded webinar and presentation slides are available below.Webinar Faculty:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.
This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.Please note that the on-demand webinar is not available for continuing education credits
Presenters: Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center, Dena Battle – KCCure, David McDermott, MD – Beth Israel Deaconess Medical Center, Brian Rini, MD – Vanderbilt University Medical Center; Date: January 7, 202001:02:23
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com